Scientists have developed a novel cancer vaccine platform that transforms the synchronised mass immune memory generated through SARS-CoV-2 infection and vaccination into a powerful ally against cancer. The study by scientists from Celloram, University Hospitals, and Case Western Reserve University was published in Nature Communications. Read More
Researchers at the Francis Crick Institute in the UK have shown that water influx is necessary for T cells to activate and divide in response to a threat. In research published in Nature Communications, the team at the Crick found that… Read More
A study led by the University of Oxford has successfully investigated human immunity against Covid-19 in people who already have antibodies, with the aim of advancing future vaccines and treatments. The results suggest that previous infection, together with vaccination, offers strong protection against the original Covid-19… Read More
Listen to this article on the DDW Podcast: Vaccination responses need to be rapid, efficacious and cost-effective if they are to outpace new viral threats emerging across the globe, says Jian He (Jason), Chemistry, Manufacturing and Controls (CMC) Head, WuXi Vaccines. Technologies that hasten… Read More
The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. With seasonal illnesses running amok in the western hemisphere at the moment, it is… Read More
News round-up for 15-19 January by DDW Digital Content Editor Diana Spencer. With seasonal illnesses running amok in the western hemisphere at the moment, it is perhaps not surprising that this week’s news highlights focus on viruses and immunity. The top stories: Antibody… Read More
With funding from MRC/UKRI, the University of Oxford has assembled a team of scientists, radiologists and clinicians to research and understand the cause and effect of varying responses to vaccination. The results will assist researchers in designing vaccines which will offer greater protection to the most… Read More
Recent SARS-CoV-2 variants such as BA.4 and BA.5 developed abilities missing from the first Omicron variants that allowed them to overcome humans’ innate immunity, according to research from University College London (UCL). The study examined viral evolution in eight Omicron variants to better understand how the… Read More
Catherine Emond is the Head of Immunology and Neuroscience at Novartis UK. She is responsible for driving long-term strategies that can help change the lives of people with challenging immunological and neurological conditions. With over two decades of leadership experience, Emond is known for her broad brand lifecycle management achievements… Read More
An effective HIV vaccine may need to prompt strong responses from CD8+ T cells to protect people from acquiring HIV, according to a study from the National Institute of Allergy and Infectious Diseases (NIAID). The researchers drew comparisons between the immune system activity of past HIV… Read More
The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. Our news highlights this week focus on research into vaccines, with… Read More
News round-up for 20-24 February by DDW Digital Content Editor Diana Spencer. Our news highlights this week focus on research into vaccines, with good news for the treatment or prevention of various challenging conditions, including Covid-19, Strep A and HIV. Particularly interesting is the announcement that a new class… Read More
A monoclonal antibody to prevent Covid-19 in vulnerable patients, AZD3152, has entered clinical trials less than 12 months after discovery. AstraZeneca has initiated the SUPERNOVA Phase I/III trial of AZD5156 (a combination of AZD3152 and cilgavimab) in pre-exposure prophylaxis of Covid-19, following the company licensing AZD3152 from… Read More
Researchers have identified 35 genes associated with long-term Lyme disease that could potentially be used as biomarkers to diagnose patients with the condition. The findings, from the Icahn School of Medicine at Mount Sinai in New York and published in the journal Cell… Read More
New research has furthered our understanding of the immune-related factors that drive infection and disease, which will be necessary for an effective tuberculosis (TB) vaccine to be developed. Researchers from the University of Oxford investigated whether previously identified correlates of protection associated with risk of full-blown TB disease could also… Read More
Biotech company Mogling Bio has successfully has completed its first seed investment round with a sole investor, Kizoo Technology Capital. Mogling Bio is developing new pharmacological approaches to rejuvenate old stem cells of the hematopoietic (blood cell formation) system. Ageing causes stem cells to lose… Read More
